Exposure to cigarette smoke impacts myeloid-derived regulatory cell function and exacerbates airway hyper-responsiveness

Laboratory Investigation

Volumn 94, Issue 12, 2014, Pages 1312-1325

  Wang, Yong ^a   Jin, Tong Huan ^a   Farhana, Aisha ^b   Freeman, Jason ^b   Estell, Kim ^c   Zmijewski, Jaroslaw W ^a   Gaggar, Amit ^a   Thannickal, Victor J ^a   Schwiebert, Lisa M ^c   Steyn, Adrie Jc ^b,d   Deshane, Jessy S ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; IL33 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; NITRIC OXIDE; SMOKE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; BRONCHIAL HYPERREACTIVITY; C57BL MOUSE; CELL CULTURE; METABOLISM; PHYSIOLOGY; SMOKE; TOBACCO;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; INTERLEUKIN-33; INTERLEUKINS; MICE; MICE, INBRED C57BL; MYELOID CELLS; NF-KAPPA B; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SMOKE; TOBACCO;

EID: 84927135099     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.126     Document Type: Article

References (53)

1. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
2. Boushey HA, Fahy JV. Basic mechanisms of asthma. Environ Health Perspect 1995;103(Suppl 6):229-233.
3. Eisenbarth SC, Cassel S, Bottomly K. Understanding asthma pathogenesis: linking innate and adaptive immunity. Curr Opin Pediatr 2004;16:659-666.
4. Fernandes PD, Landgraf RG, Britto LR, et al. Production of nitric oxide by airways neutrophils in the initial phase of murine asthma. Int Immunopharmacol 2007;7:96-102.
5. Schroder NW, Maurer M. The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007;62:579-590.
6. Walters EH, Wood-Baker R, Reid DE, et al. Innate immune activation in neutrophilic asthma. Thorax 2008;63:88-89.
7. Calhoun WJ, Reed HE, Moest DR, et al. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992;145:317-325.
8. Dupont LJ, Rochette F, Demedts MG, et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998;157:894-898.
9. Henricks PA, Nijkamp FP. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 2001;14:409-420.
10. Mathrani VC, Kenyon NJ, Zeki A, et al. Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide? Curr Med Chem 2007;14:2204-2213.
11. Rothenberg ME, Doepker MP, Lewkowich IP, et al. Cationic amino acid transporter 2 regulates inflammatory homeostasis in the lung. Proc Natl Acad Sci USA 2006;103:14895-14900.
12. Zimmermann N, Rothenberg ME. The arginine-arginase balance in asthma and lung inflammation. Eur J Pharmacol 2006;533:253-262.
13. Eisner MD. Environmental tobacco smoke and adult asthma. Exp Lung Res 2005;31(Suppl 1):8-14.
14. Eisner MD, Klein J, Hammond SK, et al. Directly measured second hand smoke exposure and asthma health outcomes. Thorax 2005;60:814-821.
15. Seymour BW, Schelegle ES, Pinkerton KE, et al. Second-hand smoke increases bronchial hyperreactivity and eosinophilia in a murine model of allergic aspergillosis. Clin Dev Immunol 2003;10:35-42.
16. Seymour BW, Pinkerton KE, Friebertshauser KE, et al. Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy. J Immunol 1997;159:6169-6175.
17. Woodruff PG, Koth LL, Yang YH, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005;172:1383-1392.
18. Maniscalco M, Di Mauro V, Farinaro E, et al. Transient decrease of exhaled nitric oxide after acute exposure to passive smoke in healthy subjects. Arch Environ Health 2002;57:437-440.
19. Maniscalco M, Vatrella A, Sofia M. Passive smoke and exhaled nitric oxide. Am J Respir Crit Care Med 2002;165:1188author reply 1188.
20. Tsuchiya M, Asada A, Kasahara E, et al. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002;105: 1155-1157.
21. Horvath I, Donnelly LE, Kiss A, et al. Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers. Respiration 2004; 71:463-468.
22. Qiu C, Li Y, Li M, et al. Anti-interleukin-33 inhibits cigarette smokeinduced lung inflammation in mice. Immunology 2013;138:76-82.
23. Wu H, Yang S, Wu X, et al. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice. Biochem Biophys Res Commun 2014;450:110-116.
24. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23: 479-490.
25. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev. Immunol 2010;10:103-110.
26. Kurowska-Stolarska M, Stolarski B, Kewin P, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009;183:6469-6477.
27. Guo Z, Wu J, Zhao J, et al. IL-33 promotes airway remodeling and is a marker of asthma disease severity. J Asthma 2014;51:1-7.
28. Farahani R, Sherkat R, Hakemi MG, et al. Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma. Adv Biomed Res 2014;3:127.
29. Kharitonov SA, Robbins RA, Yates D, et al. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:609-612.
30. Nadif R, Matran R, Maccario J, et al. Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol 2010;104:385-393.
31. Arora M, Poe SL, Oriss TB, et al. TLR4/MyD88-induced CD11bGr-1 int F4/80 non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol 2010;3:578-593.
32. Deshane J, Zmijewski JW, Luther R, et al. Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol 2011;4:503-518.
33. Mandruzzato S, Solito S, Falisi E, et al. IL4Ralpha myeloid-derived suppressor cell expansion in cancer patients. J Immunol 2009;182: 6562-6568.
34. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174.
35. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012;12:253-268.
36. Nagaraj S, Collazo M, Corzo CA, et al. Regulatory myeloid suppressor cells in health and disease. Cancer Res 2009;69:7503-7506.
37. Caramori G, Romagnoli M, Casolari P, et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 2003;58:348-351.
38. Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 2002;20:556-563.
39. Szulakowski P, Crowther AJ, Jimenez LA, et al. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:41-50.
40. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288.
41. Fridovich I. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 1986;58:61-97.
42. Fridovich I, Freeman B. Antioxidant defenses in the lung. Annu Rev Physiol 1986;48:693-702.
43. Arora M, Poe SL, Ray A, et al. LPS-induced CD11bGr1(int)F4/80 regulatory myeloid cells suppress allergen-induced airway inflammation. Int Immunopharmacol 2011;11:827-832.
44. Baccala R, Hoebe K, Kono DH, et al. TLR-dependent and TLRindependent pathways of type I interferon induction in systemic autoimmunity. Nat Med 2007;13:543-551.
45. Khoo JJ, Forster S, Mansell A. Toll-like receptors as interferonregulated genes and their role in disease. J Interferon Cytokine Res 2011;31:13-25.
46. Na HJ, Hudson SA, Bochner BS. IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils. Cytokine 2012;57: 169-174.
47. Choi YS, Park JA, Kim J, et al. Nuclear IL-33 is a transcriptional regulator of NF-kappaB p65 and induces endothelial cell activation. Biochem Biophys Res Commun 2012;421:305-311.
48. Bouffi C, Rochman M, Zust CB, et al. IL-33 markedly activates murine eosinophils by an NF-kappaB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J Immunol 2013;191:4317-4325.
49. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-3556.
50. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183-192.
51. Shaykhiev R, Krause A, Salit J, et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009;183:2867-2883.
52. Kodali V, Littke MH, Tilton SC, et al. Dysregulation of macrophage activation profiles by engineered nanoparticles. ACS Nano 2013;7: 6997-7010.
53. Thatcher TH, Benson RP, Phipps RP, et al. High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function. Am J Physiol Lung Cell Mol Physiol 2008;295:L412-L421.